Technical Analysis for QTRX - Quanterix Corporation

Grade Last Price % Change Price Change
D 14.08 1.44% 0.20
QTRX closed down 2.8 percent on Monday, January 30, 2023, on 80 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 1.44%
MACD Bearish Signal Line Cross Bearish 1.44%
20 DMA Support Bullish 1.44%
NR7 Range Contraction 1.44%
NR7-2 Range Contraction 1.44%
Narrow Range Bar Range Contraction 1.44%
Down 3 Days in a Row Weakness 1.44%
Gapped Down Weakness 1.44%
200 DMA Support Bullish -1.40%
NR7 Range Contraction -1.40%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
200 DMA Resistance about 3 hours ago
10 DMA Resistance about 3 hours ago
Rose Above Previous Day's High about 3 hours ago
Rose Above 200 DMA about 3 hours ago
Up 3% about 3 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Quanterix is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Disease Infectious Diseases Inflammation Biomarkers Urology Cardiology Neurology Quality Of Life Digital Health

Is QTRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 35.98
52 Week Low 6.31
Average Volume 288,759
200-Day Moving Average 14.19
50-Day Moving Average 13.17
20-Day Moving Average 13.76
10-Day Moving Average 14.31
Average True Range 0.87
RSI 51.92
ADX 29.01
+DI 27.31
-DI 14.11
Chandelier Exit (Long, 3 ATRs) 12.94
Chandelier Exit (Short, 3 ATRs) 14.76
Upper Bollinger Bands 15.10
Lower Bollinger Band 12.42
Percent B (%b) 0.54
BandWidth 19.48
MACD Line 0.38
MACD Signal Line 0.39
MACD Histogram -0.0104
Fundamentals Value
Market Cap 439.55 Million
Num Shares 31.7 Million
EPS -1.64
Price-to-Earnings (P/E) Ratio -8.44
Price-to-Sales 16.39
Price-to-Book 6.60
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.51
Resistance 3 (R3) 14.54 14.36 14.41
Resistance 2 (R2) 14.36 14.20 14.35 14.37
Resistance 1 (R1) 14.12 14.10 14.03 14.09 14.33
Pivot Point 13.94 13.94 13.90 13.93 13.94
Support 1 (S1) 13.70 13.78 13.61 13.67 13.43
Support 2 (S2) 13.52 13.68 13.51 13.39
Support 3 (S3) 13.28 13.52 13.36
Support 4 (S4) 13.25